Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction?
Journal
Journal of Gastroenterology and Hepatology (Australia)
Journal Volume
28
Journal Issue
1
Pages
7-9
Date Issued
2013
Author(s)
Hsu C.-S.
SDGs
Other Subjects
3 hydroxy 3 methylglutaryl coenzyme A; antivirus agent; erythropoietin; fluindostatin; geranylgeranyl pyrophosphate; hydroxymethylglutaryl coenzyme A reductase inhibitor; interleukin 28B; peginterferon; proteinase inhibitor; ribavirin; triacylglycerol; very low density lipoprotein; add on therapy; anemia; blood transfusion; decompensated liver cirrhosis; disease course; editorial; enzyme activity; fatty liver; genotype; health care quality; hepatitis C; Hepatitis C virus; human; in vitro study; lipid metabolism; lipogenesis; liver failure; liver fibrosis; liver histology; low drug dose; patient care; prevalence; priority journal; protein secretion; randomized controlled trial (topic); recommended drug dose; relapse; treatment response; triacylglycerol blood level; upregulation; virus load; virus replication
Publisher
Blackwell Publishing
Type
Editorial